Default company panoramic image

Localized Therapeutics

A Laser Gene Switch technology that turns the gene therapy process ON & OFF for a safer, less expensive and curative solution.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rochester, NY, USA
  • Currency USD
  • Founded November 2012
  • Employees 3
  • Website

Company Summary

Localized Therapeutics is a biotech R&D startup developing a first-to-market delivery system providing safety control for gene drugs called the Laser Gene Switch™ (LGS) and combines light therapy with gene therapy. LGS uses a proprietary light-inducible DNA sequence which is integrated into licensee gene drugs and offers a safety control mechanism which is missing in current gene therapy drugs. We will produce different LGS sequences per disease.


  • 0eec05ea abc9 4bfd bd4d 49888e28d03e
    V.P. Business Development

    Robin brings extensive experience in business management, product development, contracts, and international marketing and sales in genomics and medical device companies, in both start-ups and global companies. She has successfully grown and led new business segments launching products worldwide, resulting in triple digit sales growth. Robin will be working on business strategy, fund raising, strategic partnerships, and business operations.

  • Default avatar
    Dave Braverman
    V.P. Sales and Marketing

    Dave has extensive experience in high tech sales and marketing including laser instrumentation. In our company, Dave develops sales and marketing strategy, communicates with our pharmaceutical customers, and solicits funding and IP sales from them.

  • Default avatar
    Max Myakishev-Rempel

    Max has over 25 years of experience in biomedical R&D in both academic and industrial settings as illustrated by patents and research publications. He served as a PI on an NIH SBIR grant and as a collaborator on several more grants. Dr. Rempel has been doing research and development in photomedicine since 2001 and in Rochester since 2006. He has unique hands-on and administrative experience in R&D of laser-activated gene therapy.


  • Default avatar
    Hiscock & Barkley - Corporate
    Default avatar
    Mengel, Metzger, Barr & Co.